{"id":"rabavert","_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=RabAvert","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:16:43.900598+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:16:51.059557+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=RabAvert","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:16:51.742635+00:00"}},"_dailymed":{"setId":"84b7a672-eeb1-4527-84ac-68196b156be2","title":"RABAVERT (RABIES VACCINE) KIT [BAVARIAN NORDIC A/S]"},"_scrapedAt":"2026-03-28T00:03:37.855Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:16:54.069387+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT07183371","phase":"PHASE2","title":"A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2025-12-15","conditions":"Malaria,Falciparum","enrollment":360},{"nctId":"NCT04127786","phase":"PHASE3","title":"Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of Adults","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2019-10-21","conditions":"Rabies, Healthy Volunteers","enrollment":1708},{"nctId":"NCT07399951","phase":"EARLY_PHASE1","title":"Washington University WU 409: Immune Responses to Rabies Vaccine.","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2023-07-18","conditions":"Healthy Participants","enrollment":30},{"nctId":"NCT03961555","phase":"PHASE2","title":"Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies","status":"COMPLETED","sponsor":"Synermore Biologics Co., Ltd.","startDate":"2019-09-03","conditions":"Rabies","enrollment":448},{"nctId":"NCT03965962","phase":"PHASE3","title":"Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2019-07-01","conditions":"Rabies (Healthy Volunteers)","enrollment":640},{"nctId":"NCT04410900","phase":"PHASE1","title":"Vaccine Responsiveness After CAR-T Cell Therapy","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2020-08-03","conditions":"B-Cell Neoplasm","enrollment":49},{"nctId":"NCT04882514","phase":"PHASE1, PHASE2","title":"A Trial of a Peptide-based Group A Streptococcal (GAS) Vaccine Candidate in Healthy Individuals.","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2022-11-07","conditions":"Group A Streptococcal Infection","enrollment":30},{"nctId":"NCT06048770","phase":"PHASE1","title":"A Study of RBI-4000 in Healthy Participants","status":"TERMINATED","sponsor":"Replicate Bioscience","startDate":"2023-09-01","conditions":"Healthy Volunteers","enrollment":89},{"nctId":"NCT04661579","phase":"PHASE2","title":"Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy","status":"COMPLETED","sponsor":"PATH","startDate":"2020-11-06","conditions":"Plasmodium Falciparum","enrollment":620},{"nctId":"NCT04019444","phase":"PHASE1","title":"Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-09-19","conditions":"Rabies, Rabies Immunisation","enrollment":50},{"nctId":"NCT04062669","phase":"PHASE1","title":"A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-08-13","conditions":"Virus Diseases","enrollment":160},{"nctId":"NCT05937113","phase":"PHASE4","title":"Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally","status":"COMPLETED","sponsor":"Vietnam Military Medical University","startDate":"2020-06-13","conditions":"Rabies","enrollment":220},{"nctId":"NCT02374814","phase":"PHASE4","title":"Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis","status":"COMPLETED","sponsor":"State University of New York - Upstate Medical University","startDate":"2015-03-24","conditions":"Rabies","enrollment":60},{"nctId":"NCT03145766","phase":"PHASE2","title":"Immunogenicity and Safety of a Purified Vero Rabies Vaccine","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2017-04-17","conditions":"Rabies Virus","enrollment":320},{"nctId":"NCT00023504","phase":"PHASE4","title":"Antibody Production in Immune Disorders","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2002-06-13","conditions":"Primary Immune Deficiency","enrollment":21},{"nctId":"NCT02040090","phase":"PHASE2, PHASE3","title":"Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects","status":"COMPLETED","sponsor":"Kamada, Ltd.","startDate":"2013-04","conditions":"Rabies","enrollment":118},{"nctId":"NCT03656198","phase":"PHASE4","title":"Non-specific Effects of Rabies Vaccine","status":"COMPLETED","sponsor":"Ross University School of Veterinary Medicine","startDate":"2018-08-29","conditions":"Influenza-like Illness, Upper Respiratory Disease, Diarrhea","enrollment":546},{"nctId":"NCT02564471","phase":"PHASE4","title":"Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.","status":"COMPLETED","sponsor":"State University of New York - Upstate Medical University","startDate":"2016-11-11","conditions":"Rabies","enrollment":103},{"nctId":"NCT00223990","phase":"PHASE2","title":"Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2005-04-08","conditions":"Malaria, Falciparum","enrollment":400},{"nctId":"NCT03264157","phase":"PHASE2, PHASE3","title":"Safety and Effectiveness of BPL HRIG With Active Rabies Vaccine in Healthy Subjects","status":"COMPLETED","sponsor":"Bio Products Laboratory","startDate":"2017-12-08","conditions":"Healthy","enrollment":162},{"nctId":"NCT03741270","phase":"PHASE4","title":"Safety of Rabivax-S for Pre-exposure Prophylaxis","status":"COMPLETED","sponsor":"Ross University School of Veterinary Medicine","startDate":"2018-10-24","conditions":"Rabies Vaccine Adverse Reaction","enrollment":159},{"nctId":"NCT02956746","phase":"PHASE1, PHASE2","title":"A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines","status":"COMPLETED","sponsor":"Synermore Biologics Co., Ltd.","startDate":"2016-08","conditions":"Human Rabies","enrollment":164},{"nctId":"NCT00317473","phase":"PHASE1","title":"Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2003-06","conditions":"Plasmodium Falciparum Malaria","enrollment":135},{"nctId":"NCT00308061","phase":"PHASE1","title":"Safety Study of Candidate Malaria Vaccine FMP1/AS02A in Healthy Adults in Bandiagara, Mali","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2003-07","conditions":"Malaria","enrollment":40},{"nctId":"NCT00349713","phase":"PHASE1","title":"FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, Mali","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2004-11","conditions":"Malaria, Plasmodium Falciparum Malaria","enrollment":60},{"nctId":"NCT01063140","phase":"","title":"Rabies Immune Plasma Booster Study","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2009-01","conditions":"Rabies","enrollment":491},{"nctId":"NCT01044199","phase":"NA","title":"Study of Intradermal Administration of PCEC Rabies Vaccine","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2009-02","conditions":"Rabies Prevention, Rabies Exposure","enrollment":130},{"nctId":"NCT00358332","phase":"PHASE1","title":"Phase I Pediatric FMP2.1/AS02A Trial in Mali","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2006-11","conditions":"Plasmodium Falciparum Malaria","enrollment":100}],"_emaApprovals":[],"_faersSignals":[{"count":8,"reaction":"IMMUNE THROMBOCYTOPENIC PURPURA"},{"count":7,"reaction":"HEADACHE"},{"count":3,"reaction":"DRUG INEFFECTIVE"},{"count":3,"reaction":"NAUSEA"},{"count":3,"reaction":"PRODUCT ADMINISTERED AT INAPPROPRIATE SITE"},{"count":3,"reaction":"PYREXIA"},{"count":3,"reaction":"SYNCOPE"},{"count":2,"reaction":"ABDOMINAL DISCOMFORT"},{"count":2,"reaction":"ABDOMINAL PAIN"},{"count":2,"reaction":"ANXIETY"}],"_approvalHistory":[],"publicationCount":17,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["active rabies vaccine","RabAver"],"phase":"marketed","status":"active","brandName":"RabAvert","genericName":"RabAvert","companyName":"Synermore Biologics Co., Ltd.","companyId":"synermore-biologics-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":2,"withResults":1},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:16:54.069387+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}